news

SilcsBio, LLC Announces Release of CGenFF 2.3.0

Baltimore, MD, 26 April, 2019 In ongoing efforts to improve the coverage of the CGenFF program, version 2.3.0 of the CGenFF program improves support for a variety of molecules via explicit parametrization of the molecules outlined below and features improvements for halogen-protein interactions. Molecules explicitly parametrized The functional groups in these molecules were previously accessible […]

Continue Reading

SilcsBio, LLC Receives NIH Funding to Expand Offerings in Biologics

FOR IMMEDIATE RELEASE: April 11, 2019 Ken Malone SilcsBio, LLC 410.929.2305 Ken.Malone@silcsbio.com ¬† SilcsBio, LLC Receives NIH Funding to Expand Offerings in Biologics   Baltimore, Maryland:¬†SilcsBio, LLC announced today a $225,000 award from the National Institutes of Health to expand on its broadly used software, SILCS, to enable its use with biological therapeutics, especially for […]

Continue Reading